Ideal Adjuvant Radiation Candidates Identified

Share this article:

Researchers have identified what they believe are the ideal candidates for adjuvant radiotherapy following radical prostatectomy (RP), according to a recent study.

These include prostate cancer (PCa) patients who have two of the following pathologic features found at surgery: Gleason score of 8 or higher, clinical stage pT3/pT4 disease, and positive lymph nodes, researchers Firas Abdollah, MD, and colleagues at Vita-Salute University in San Raffaele, Milan, Italy, reported online ahead of print in European Urology.

They evaluated 1,049 PCa patients treated with RP and extended pelvic lymph node dissection alone or in combination with adjuvant treatments. All patients had positive surgical margins, pT3/pT4 disease or both, with or without positive lymph nodes.

On multivariable analyses, the presence of at least two of the aforementioned pathologic features was significantly associated with lower cancer-specific and overall mortality.

Of the entire cohort, 43.6% had none of the pathologic features, 22.1% had one, 20.7% had two, and 13.6% had all three.

Share this article:
You must be a registered member of RUN to post a comment.

More in Prostate Cancer

Sexual Function Preserved in Prostate Cancer Combination Therapy

Sexual Function Preserved in Prostate Cancer Combination Therapy

High rates of preserved sexual function with combination beam plus brachytherapy.

Radical Prostatectomy Rates Rising

Radical Prostatectomy Rates Rising

Utilization rates jumped by double digits across prostate cancer risk groups from 2004 to 2011.

Male Pattern Baldness Linked with Prostate Cancer

Male Pattern Baldness Linked with Prostate Cancer

Men with male pattern baldness may face a higher risk of aggressive prostate cancer.